Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1
Bernd Höppe(University of Bonn), Harpreet Sidhu(Unknown), Poonam Kaul, Gerd von Unruh(University of Bonn), Norbert Laube(University of Bonn), Bodo B. Beck(University of Cologne), A. Tischer(University of Bonn), Albrecht Hesse(University Hospital Bonn), N. Gatter(University Hospital Cologne)
Cited by 214
Related Papers
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4
|Nature Genetics|2006|573
History, epidemiology and regional diversities of urolithiasis
|Pediatric Nephrology|2008|460
The primary hyperoxalurias
|Kidney International|2009|373
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
|Nephrology Dialysis Transplantation|2012|335